173 related articles for article (PubMed ID: 12174889)
21. Design, synthesis, and in vitro activity of catamphiphilic reverters of multidrug resistance: discovery of a selective, highly efficacious chemosensitizer with potency in the nanomolar range.
Teodori E; Dei S; Quidu P; Budriesi R; Chiarini A; Garnier-Suillerot A; Gualtieri F; Manetti D; Romanelli MN; Scapecchi S
J Med Chem; 1999 May; 42(10):1687-97. PubMed ID: 10346921
[TBL] [Abstract][Full Text] [Related]
22. Multidrug resistance reversal activity of permethyl ningalin B amide derivatives.
Tao H; Hwang I; Boger DL
Bioorg Med Chem Lett; 2004 Dec; 14(24):5979-81. PubMed ID: 15546712
[TBL] [Abstract][Full Text] [Related]
23. MDR-reversal activity of chalcones.
Ivanova A; Batovska D; Engi H; Parushev S; Ocsovszki I; Kostova I; Molnar J
In Vivo; 2008; 22(3):379-84. PubMed ID: 18610751
[TBL] [Abstract][Full Text] [Related]
24. Antineoplastic agents 491. Synthetic conversion of aaptamine to isoaaptamine, 9-demethylaaptamine, and 4-methylaaptamine.
Pettit GR; Hoffmann H; Herald DL; McNulty J; Murphy A; Higgs KC; Hamel E; Lewin NE; Pearce LV; Blumberg PM; Pettit RK; Knight JC
J Org Chem; 2004 Apr; 69(7):2251-6. PubMed ID: 15049616
[TBL] [Abstract][Full Text] [Related]
25. The role of structural factors in the kinetics of cellular uptake of pyrazoloacridines and pyrazolopyrimidoacridines: implications for overcoming multidrug resistance towards leukaemia K562/DOX cells.
Tarasiuk J; Majewska E; Seksek O; Rogacka D; Antonini I; Garnier-Suillerot A; Borowski E
Biochem Pharmacol; 2004 Nov; 68(9):1815-23. PubMed ID: 15450947
[TBL] [Abstract][Full Text] [Related]
26. Reversal of multidrug resistance of cancer cells in vitro: modification of drug resistance by selected carotenoids.
Gyémánt N; Tanaka M; Molnár P; Deli J; Mándoky L; Molnár J
Anticancer Res; 2006; 26(1A):367-74. PubMed ID: 16475720
[TBL] [Abstract][Full Text] [Related]
27. Induction of apoptosis and necrosis by resistance modifiers benzazoles and benzoxazines on tumour cell line mouse lymphoma L5718 Mdr+cells.
Varga A; Aki-Sener E; Yalcin I; Temiz-Arpaci O; Tekiner-Gulbas B; Cherepnev G; Molnar J
In Vivo; 2005; 19(6):1087-91. PubMed ID: 16277027
[TBL] [Abstract][Full Text] [Related]
28. Allosteric inhibitors of Akt1 and Akt2: a naphthyridinone with efficacy in an A2780 tumor xenograft model.
Bilodeau MT; Balitza AE; Hoffman JM; Manley PJ; Barnett SF; Defeo-Jones D; Haskell K; Jones RE; Leander K; Robinson RG; Smith AM; Huber HE; Hartman GD
Bioorg Med Chem Lett; 2008 Jun; 18(11):3178-82. PubMed ID: 18479914
[TBL] [Abstract][Full Text] [Related]
29. In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells.
Gyémánt N; Tanaka M; Antus S; Hohmann J; Csuka O; Mándoky L; Molnár J
In Vivo; 2005; 19(2):367-74. PubMed ID: 15796199
[TBL] [Abstract][Full Text] [Related]
30. Prolongation of pentoxifylline aliphatic side chain positively affects the reversal of P-glycoprotein-mediated multidrug resistance in L1210/VCR line cells.
Docolomanský P; Fialová I; Barancík M; Rybár A; Breier A
Gen Physiol Biophys; 2005 Dec; 24(4):461-6. PubMed ID: 16474189
[TBL] [Abstract][Full Text] [Related]
31. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
32. Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells.
Pajak B; Molnar J; Engi H; Orzechowski A
In Vivo; 2005; 19(6):1101-4. PubMed ID: 16277030
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of 7-oxo-7H-naphtho[1,2,3-de]quinoline derivatives as potential anticancer agents active on multidrug resistant cell lines.
Dzieduszycka M; Bontemps-Gracz MM; Stefańska B; Martelli S; Piwkowska A; Arciemiuk M; Borowski E
Bioorg Med Chem; 2006 May; 14(9):2880-6. PubMed ID: 16458007
[TBL] [Abstract][Full Text] [Related]
34. Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives.
Bisi A; Meli M; Gobbi S; Rampa A; Tolomeo M; Dusonchet L
Bioorg Med Chem; 2008 Jul; 16(13):6474-82. PubMed ID: 18522868
[TBL] [Abstract][Full Text] [Related]
35. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
Rothenborg-Jensen L; Hansen HF; Wessel I; Nitiss JL; Schmidt G; Jensen PB; Sehested M; Jensen LH
Anticancer Drug Des; 2001 Dec; 16(6):305-15. PubMed ID: 12375883
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
Hasegawa T; Bai J; Dai J; Bai L; Sakai J; Nishizawa S; Bai Y; Kikuchi M; Abe M; Yamori T; Tomida A; Tsuruo T; Hirose K; Ando M
Bioorg Med Chem Lett; 2007 Jul; 17(13):3722-8. PubMed ID: 17490878
[TBL] [Abstract][Full Text] [Related]
37. The role of stereoselectivity of chemosensitizers in the reversal of multidrug resistance of mouse lymphoma cells.
Szabó D; Molnár J
Anticancer Res; 1998; 18(4C):3039-44. PubMed ID: 9713506
[TBL] [Abstract][Full Text] [Related]
38. Coumarin derivatives with tumor-specific cytotoxicity and multidrug resistance reversal activity.
Kawase M; Sakagami H; Motohashi N; Hauer H; Chatterjee SS; Spengler G; Vigyikanne AV; Molnár A; Molnár J
In Vivo; 2005; 19(4):705-11. PubMed ID: 15999537
[TBL] [Abstract][Full Text] [Related]
39. Effects of nontoxic heat shock protein 90 inhibitor peptide derivatives on reversal of MDR of tumor cells.
Molnár J; Engi H; Mándi Y; Somlai C; Penke B; Szabó A; Orosz A
In Vivo; 2007; 21(2):429-33. PubMed ID: 17436599
[TBL] [Abstract][Full Text] [Related]
40. Multidrug resistance reversing activity of newly developed phenothiazines on P-glycoprotein (ABCB1)-related resistance of mouse T-lymphoma cells.
Spengler G; Takács D; Horváth A; Riedl Z; Hajós G; Amaral L; Molnár J
Anticancer Res; 2014 Apr; 34(4):1737-41. PubMed ID: 24692704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
